Company Filing History:
Years Active: 2014-2019
Title: Lizbeth Celeste DeSelm: Innovator in Pharmaceutical Chemistry
Introduction
Lizbeth Celeste DeSelm is a prominent inventor based in Melrose, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 13 patents to her name, her work has the potential to impact the treatment of various hyperproliferative disorders.
Latest Patents
Among her latest patents are "Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors," which describes novel azaquinazoline carboxamide derivatives that can be employed for the treatment of hyperproliferative disorders. Another significant patent is "Heteroaryl compounds as IRAK inhibitors and uses thereof," which relates to compounds useful as IRAK inhibitors and their pharmaceutically acceptable compositions.
Career Highlights
Lizbeth is currently associated with Merck Patent GmbH, where she continues to innovate and develop new pharmaceutical solutions. Her work is characterized by a strong focus on creating effective inhibitors that can lead to advancements in medical treatments.
Collaborations
Throughout her career, Lizbeth has collaborated with notable colleagues, including Andreas Goutopoulos and Bayard R Huck. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Lizbeth Celeste DeSelm is a trailblazer in the field of pharmaceutical chemistry, with a strong portfolio of patents that reflect her innovative spirit. Her contributions are paving the way for new treatments and therapies in the medical field.